title: Highlights from the 2016 Schizophrenia International Research Society Conference, April 2-6, 2016.
abstract: The 2016 Schizophrenia International Research Society (SIRS) Conference, held in Florence, Italy, attracted approximately 1,800 attendees from over 54 countries to the stately Firenze Fiera Conference Center from April 2-6, 2016. Providing plenary sessions, special sessions, symposia, workshops, oral presentations and poster presentations, this 5th Biennial SIRS Conference focused on "Deconstructing Schizophrenia towards Targeted Treatment." In conjunction with the Schizophrenia Research Forum, a Web project of the Brain and Behavior Research Foundation, and with our thanks to the SIRS organizers and staff, we bring you the following selected highlights.
authors.forename: Michele
authors.initials: M
authors.lastname: Solis
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects*; D003423:Critical Period, Psychological; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology*; D059290:Dopaminergic Neurons; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D017072:Neostriatum / Q000378:metabolism; D010597:Pharmacogenetics; D010617:Phenanthridines / Q000494:pharmacology*; D017447:Receptors, Dopamine D1 / Q000819:agonists; D017448:Receptors, Dopamine D2 / Q000235:genetics; D012559:Schizophrenia / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D014808:Vitamin D Deficiency / Q000453:epidemiology
chemical_list: D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D015525:Fatty Acids, Omega-3; D010617:Phenanthridines; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; C061532:dihydrexidine; D004298:Dopamine